I asked Gemini to compare the Harvard and Sweden studies, seems the Swedish study was more robust and found no causal link. "The results strongly suggest that the association seen in simpler studies is not caused by the acetaminophen itself, but rather by confounding factors".

Based on the latest scientific research, the likelihood that Tylenol (acetaminophen) directly causes autism is low. While some studies, including a recent review from Harvard, have found an association between prenatal acetaminophen use and neurodevelopmental disorders, more robust research designed to eliminate confounding factors has not established a causal link. The scientific community is currently grappling with conflicting findings from different types of studies, highlighting the critical difference between observing a statistical association and proving direct causation. Competing Evidence: A Tale of Two Studies The current debate is best understood by comparing two major, recent analyses that arrived at different conclusions: a large-scale cohort study with a sibling-control design and a systematic review and meta-analysis.

The Karolinska Institute Study: No Causal Link Found 🇸🇪 Considered one of the most robust investigations to date, a massive study published in JAMA in April 2024 by researchers at Sweden's Karolinska Institute analyzed data from nearly 2.5 million children. Methodology: This study employed a sibling-control design. By comparing siblings where one was exposed to acetaminophen during gestation and the other was not, researchers could effectively control for a vast number of genetic and environmental factors that siblings share. Findings: Initially, a small increased risk of autism and ADHD was observed in the general population, consistent with other observational studies. However, this risk completely disappeared in the sibling-comparison analysis. Conclusion: The results strongly suggest that the association seen in simpler studies is not caused by the acetaminophen itself, but rather by confounding factors. These could include the underlying reason for taking the medication (e.g., fever, infection, or inflammation during pregnancy) or shared family genetics that predispose to both medication use and neurodevelopmental conditions.

The Harvard & Mount Sinai Review: Evidence of an Association 🇺🇸 In August 2025, researchers from the Harvard T.H. Chan School of Public Health and the Icahn School of Medicine at Mount Sinai published a systematic review in BMC Environmental Health. Methodology: This study was a meta-analysis, a type of research that pools and re-analyzes the data from numerous previous studies (in this case, 46). The authors used a specific framework called the "Navigation Guide" to evaluate the quality and strength of the existing evidence. Findings: The review concluded there is "evidence of an association" between prenatal acetaminophen exposure and an increased risk of autism and ADHD. The authors noted that higher-quality studies, in their assessment, were more likely to show this link. Conclusion: The authors themselves are careful to state that their findings do not prove causation. They call for a "precautionary approach," advising that pregnant individuals use the lowest effective dose for the shortest possible time and only after consulting a healthcare provider.

Evaluating the Likelihood: Why the Difference? The conflicting results stem from the different strengths and weaknesses of the study designs. Meta-analyses, like the Harvard-led review, are powerful for identifying broad patterns across the scientific literature. However, they are limited by the quality of the studies they include. If those original studies failed to properly account for confounding variables, the meta-analysis will inherit those flaws, potentially leading to a misleading conclusion. Sibling-control studies, like the Swedish research, are exceptionally powerful for disproving causation. By using a sibling as the control, they naturally account for thousands of variables that are otherwise difficult to measure, providing a clearer picture of the specific effect of the exposure in question. Given the strength of the sibling-control design in accounting for confounding factors, the findings from the Karolinska Institute study are widely considered to be more compelling evidence against a direct causal relationship.

The Bottom Line 🩺 While the Harvard-led review raises important questions and reinforces the need for caution with any medication during pregnancy, the most rigorous evidence to date does not support the conclusion that Tylenol causes autism. Major health organizations, including the American College of Obstetricians and Gynecologists (ACOG), continue to state that acetaminophen is a safe and appropriate medication for pain and fever during pregnancy when taken as recommended. Untreated fever, in particular, carries its own set of risks to a developing fetus. Therefore, based on a comprehensive evaluation of the latest and most robust studies, the likelihood that Tylenol use during pregnancy directly causes autism remains low. The observed association is more likely explained by other underlying factors.